期刊文献+

2型糖尿病肾脏疾病躯体危险因素的系统评价 被引量:3

Physical Risk Factors for Type 2 Diabetic Kidney Disease: A Systematic Review
原文传递
导出
摘要 目的系统评价躯体因素与2型糖尿病(T2DM)肾脏疾病的相关性。方法计算机检索MEDLINE、EMbase、CBM、CNKI和VIP数据库,收集所有关于T2DM肾脏疾病躯体危险因素的研究,检索时限截至2012年12月。由2名研究者按照纳入与排除标准筛选文献,提取数据和评价纳入研究的方法学质量后,采用RevMan5.2软件进行Meta分析。结果共纳入11个研究,12957例T2DM患者。其中9个研究为横断面研究,1个为病例-对照研究,1个为队列研究。研究结果显示:与T2DM肾脏疾病相关的躯体因素主要有糖尿病病程[OR=1.11,95%CI(1.05,1.18)]、腰围[OR=1.02,95%CI(1.00,1.04)]、空腹血糖[OR=1.11,95%CI(1.07,1.16)]、糖化血红蛋白[OR=1.20,95%CI(1.06,1.36)]、收缩压[OR=1.03,95%CI(1.02,1.05)]、舒张压[OR=2.41,95%CI(1.15,4.64)]、甘油三酯[OR=1.24,95%CI(1.02,1.51)]、高密度脂蛋白[OR=0.558,95%CI(0.369,0.844)]、血尿酸[OR=1.005,95%CI(1.002,1.009)]、血尿素氮水平[OR=1.58,95%CI(1.37,1.82)]、肾脏疾病史[OR=3.26,95%CI(1.20,8.87)]及肾脏疾病家族史[OR=1.83,95%CI(1.29,2.60)]。结论现有证据表明,与T2DM并发肾脏疾病相关的躯体因素众多。受纳入研究数量和质量所限,本研究结论尚需更多高质量研究进一步验证。 Objective To systematically review the independent physical risk factors associated with diabetic kid- ney disease (DKD) in patients with type 2 diabetes mellitus. Methods We searched MEDLINE, EMbase, CBM, CNKI and VIP for all studies about the independent physical risk factors associated with diabetic kidney disease (DKD) in pa- tients with type 2 diabetes mellitus up to December 2012. Two reviewers independently screened studies according to the inclusion and exclusion criteria, extracted data, and assessed the methodological quality of included studies. Then meta- analysis was conducted using RevMan 5.2 software. Results A total of 11 studies involving 12 957 patients with type 2 diabetes were included. Of these 11 studies, 9 were cross-sectional studies, two were cohort studies, and one was case- control study. The results showed that: the main physical factors associated with DKD were: duration of diabetes (OR= 1.11, 95%CI 1.05 to 1.18), waist circumference (OR=1.02, 95%CI 1.00 to 1.04), fasting glucose (OR=1.11, 95%CI 1.07 to 1.16), glycosylated hemoglobin (OR=1.20, 95%CI 1.06 to 1.36), systolic blood pressure (OR=1.03, 95%CI 1.02 to 1.05), diastolic blood pressure (OR=2.41, 95%CI 1.15 to 4.64), triglycerides (OR=1.24, 95%CI 1.02 to 1.51), high-density lipoprotein (OR=0.558, 95%CI 0.369 to 0.844), blood uric acid (OR=1.005, 95%CI 1.002 to 1.009), blood urea nitrogen (OR=1.58, 95%CI 1.37 to 1.82), past history of kidney disease (OR=3.26, 95%CI 1.20 to 8.87) and family history of kidney disease (OR=1.83, 95%CI 1.29 to 2.60). Conclusion Current evidence shows that multiple physical factors were associated with the development of type 2 diabetic kidney disease. However, due to the limited quantity and quality of the included stud- ies, more high quality studies are needed to verify the conclusion.
出处 《中国循证医学杂志》 CSCD 2014年第10期1201-1205,共5页 Chinese Journal of Evidence-based Medicine
关键词 2型糖尿病 糖尿病肾病 躯体因素 系统评价 Type 2 diabetes mellitus Diabetic kidney disease Physical factor Systematic review
  • 相关文献

参考文献26

  • 1Collins AJ, Foley RN, Herzog C, et al. United States Renal Data Sys- tem 2011 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis, 2012, 59(1 Suppl 1): 1-420.
  • 2Levin A, Rocco M. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am JKidney Dis, 2007, 49(2 Suppl 2): S12-154.
  • 3Gowdak LH, Arantes RL, Paula FJ, et al. Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patients. Ren Fail, 2007, 29(5): 559-565.
  • 4Keane WF, Zhang Z, Lyle PA, et al. Risk scores for predicting out- comes in patients with type 2 diabetes and nephropathy: the RE- NAAL study. Clin J Am Soc Nephrol, 2006, 1(4): 761-767.
  • 5Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med, 2010, 268(5):456-467.
  • 6Reutens AT, Atkins RC. Epidemiology of diabetic nephropathy. Contrib Nephrol, 2011, 170: 1-7.
  • 7Tang SC. Diabetic nephropathy: a global and growing threat. Hong Kong Med J, 2010, 16(4): 244-245.
  • 8胡仁明.糖尿病肾脏病变的诊断和治疗[J].中国医学前沿杂志(电子版),2012,4(3):36-38. 被引量:5
  • 9Alberti KG, Zimmet PZ. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Diabet Med, 1998, 15(7): 539-553.
  • 10Gavin JR, Alberti K, Davidson MB, et al. Report of the Expert Com- mittee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997, 20: 1183-1197.

二级参考文献67

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3055
  • 2杜宏,唐政,陈惠萍,赵明.2型糖尿病肾病患者肾脏预后因素分析[J].中国医师杂志,2006,8(5):652-653. 被引量:5
  • 3谌贻璞.代谢综合征肾损害:已知与未知[J].中华肾脏病杂志,2006,22(7):381-382. 被引量:12
  • 4Strazzullo P, Barbato A, Siani A. et al. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population [J]. Metabolism, 2008, 57(3): 355-361.
  • 5Zarich SW. Metabolic syndrome, diabetes and cardiovascular events:current controversies and recommendations [J]. Minerva Cardioangiol, 2006, 54(2): 195-214.
  • 6Schelling JR, Sedor JR. The metabolic syndrome as a risk factor for chronic kidney disease, more than a fat chance? [J]. J Am Soc Nephrol, 2004, 15 ( 11 ) : 2773-2774.
  • 7American Diabetes Association. Diagnosis and classification of diabetes mellitus [J]. Diabetes Care, 2005, 28(Suppl 1):37-42.
  • 8Kopple JD. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure [J]. Am J Kidney Dis, 2001, 37 (1 Suppl 2):66-70.
  • 9Chen J, Muntner Po Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults [J]. Ann Intern Med, 2004, 140(3): 167-174.
  • 10Ninomiya T, Kiyohara Y, Kubo M, et al. Metabolic Syndrome and CKD in a General Japanese Population:The Hisayama Study [J]. Am J Kidney Dis, 2006, 48(3) : 383-391.

共引文献64

同被引文献53

引证文献3

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部